EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Pharma Patent Expirations: How European Generics are changing the Market

    The industry whereby most products are pharmaceuticals is usually fueled by innovation research and last but not the least patents Patents enable drug manufacturers to sell a new drug for a certain amount of time so they can indeed recover their research and development costs However once the patents for the medicine expire any different company can legally manufacture the copy of the same drug a...

    Revolutionizing Biomanufacturing: Single-use Systems at the Forefront

    In the rapidly evolving field of biomanufacturing singleuse systems have emerged as a gamechanger With their ability to optimize efficiency reduce contamination risks and lower costs these systems are revolutionizing the way biopharmaceuticals are produced

    What Is Pharmaceutical Logistics? Top 7 Pharmaceutical Logistics Challenges and Solutions

    Pharmaceutical logistics is an important part of the health systems ecosystem and ensures that drugs and medical products that are conscious of patients safely effectively and on time In the core pharmaceutical logistics management includes planning implementation and control of movement and storage of pharmaceutical goods in the supply chain Given the sensitive nature of these products it is nece...

    The Cost of Uncertainty: How Analytical Chemistry Drives Billion-Dollar Decisions in Pharma

    In pharmaceutical development uncertainty is not an abstract scientific inconvenience It has a cost a timeline a regulatory consequence and ultimately a patient impact A promising medicine may have strong biological rationale compelling early data and significant commercial potential yet still face a fundamental question do we truly understand the product well enough to develop manufacture approve...

    The Rise of Continuous Clinical Trials: Redefining Drug Development

    The conventional clinical trial is a disposable asset A sponsor writes a protocol for a single compound activates a network of sites recruits a control group reads out and then dismantles everything it has built When the next candidate arrives often in the same disease often at the same hospitals

    Considerations and Functional Elements of Closed Systems: Isolators and Single Use Systems

    Advances in technology have demonstrated the feasibility of using isolators and singleuse systems SUS in routine pharmaceutical manufacturing operations particularly in aseptic processing Their implementation has significantly reduced the risk of chemical particulate and microbiological contamination

TOP ARTICLES

press releases Read more...

BioLife receives US patent for novel effervescent tablet technology for oral peptide delivery

BioLife announced today that the US Patent and Trademark Office has granted US Patent B for its novel oral peptide delivery technology via effervescent tablets It was developed for current and future peptide therapies for obesity diabetes and metabolic disorders

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Prelude Therapeutics Incorporated Nasdaq PRLD a precision oncology company today announced that the US Food and Drug Administration FDA cleared the Company to proceed with a Phase study under

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Electra Therapeutics a clinicalstage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immunemediated diseases and cancer today announced

Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug

Insilico Medicine Insilico HKEX a clinicalstage biotechnology company powered by generative AI today announced that it has dosed the first patient with Rentosertib known as ISM INS

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

Renova Pharmaceuticals Launches First Three US Generic Products

Renova Pharmaceuticals has launched its first three generic products in the US marking a major milestone as the company moves from developing its product and regulatory pipeline to establishing a commercial presence in the US generics market

Community Clinical Research Joins PhaseWell Research to Expand CNS Clinical Trial Access in Te

PhaseWell Research has partnered with Community Clinical Research CCR in Austin Texas to strengthen its inpatient central nervous system CNS research capabilities and expand access to clinical trials across Texas

Sysmex Europe and Cytek Biosciences collaborate to expand access to advanced clinical flow cytometry

Sysmex Europe SE and Cytek Biosciences Inc have announced a strategic collaboration across more than a dozen European countries to improve clinical flow cytometry workflows and expand access to advanced diagnostic solutions

Ratio Therapeutics and RayzeBio enter collaboration to advance novel radiopharmaceutical programme

Ratio Therapeutics Inc has entered into a research collaboration and licence agreement with RayzeBio Inc to advance a new radiopharmaceutical programme focused on two undisclosed targets

HCW Biologics Signs Exclusive Distribution Agreement with Akron Biotech for HCW11-006

HCW Biologics Inc a USbased clinicalstage biopharmaceutical company has entered into an exclusive distribution agreement with Akron Biotech to commercialise HCW as a reagent for producing highly functional human CART cells

Sernova and Seraxis to Merge and Form BetaNova Biotherapeutics for Type 1 Diabetes Cell Replacement

Sernova Biotherapeutics Inc and Seraxis Holdings Inc have entered into a definitive merger agreement to combine their technologies and create BetaNova Biotherapeutics a clinicalstage biotechnology